Previous observations have demonstrated a depression in cerebral blood flow during controlled hypotension with ganglionic blocking agents. Cerebral blood flow is also decreased when normotensive individuals are made hypertensive by the administration of vasopressor agents. The opposite response is observed when hypotensive individuals are made normotensive by the administration of these same agents, in which circumstance cerebral blood flow is increased. E XPERIMENTAL work on the cerebral circulation in laboratory animals has indicated that the volume of blood
flowing through the brain parallels the systemic blood pressure.' Observations which were made following the administration of dihydroergocornine to normotensive subjects2 showed that cerebral blood flow is not altered following minor reductions in blood pressure. However, when the blood pressure is reduced to moderate or marked hypotensive levels, the cerebral blood flow decreases.3 When norepinephrine is infused intravenously into normotensive subjects the cerebral blood flow decreases as the blood pressure rises4' 5 to hypertensive levels, probably indicative of preferential cerebral vasoconstriction. It has been suggested that this latter response might have a harmful effect on the brain by superimposing additional cerebral vasoconstriction when such vasopressor agents as norepinephrine are used for the treatment of hypotensive states.4 The purpose of the current report was to study the effect of Aramine, levo 1-(m-hydroxphenyl)-2-amino-ipropanol, supplied through the courtesy of Sharp and Dohme, Inc. Norepinephrine supplied through the courtesy of Winthrop-Stearns, Inc. 265 a synthetic vasopressor amine (Aramine) on the cerebral circulation in the normotensive individual and to compare this response with that of norepinephrine. Additional comparisons were made on the response of normotensive subjects who have been made hypertensive by giving a vasopressor agent, as compared with the response when the blood pressure was only returned to control levels in patients who were previously made hypotensive by a ganglionic blocking agent.
METHODS
Cerebral hemodynamic studies were made on 22 normal subjects. The patients were divided into two groups. There were 11 patients in group 1, all of whom were normotensive. Seven of them received Aramine and four received norepinephrine. Only four patients received norepinephrine because our observations merely confirmed the previously reported observations of others,4'°which indicated that cerebral blood flow was slightly depressed by this agent when administered to normotensive subjects. Therefore, further studies did not appear to be indicated. Cerebral blood flow was determined by the nitrous oxide method.6 Analytic technics and procedures used have previously been described.7 After suitable control observations, the vasopressor agent was administered by continuous intravenous infusion at a rate adequate to increase the blood pressure about 30 to 40 per cent. The concentration of Aramine was 50 mg. per liter in normal saline. The concentration of norepinephrine was 4 mg. per liter. After the blood pressure was stabilized at the hypertensive levels for 10 to 15 minutes the cerebral blood flow determinations were again repeated.
Control observations on the 11 patients in group 2 were made in a similar manner to the control Circulation, Volume X, August, 1954 observations on the patients in group 1. Then the blood pressure was reduced by a continuous infusion of one of the ganglionic blocking agents (hexamethonium, Pendiomide* or Arfonadi) until maxi-* Pendiomide (pentamethyl-diethyl-3-azo-pentane-l,5-diammoniumdibromide) furnished through the courtesy of Ciba Pharmaceuticals, Inc. t Arfonad (d-3,4(l',3'-dibenzyl-2'-keto-imidazo-mum reduction in blood pressure was obtained or the mean blood pressure was approximately 50 mm.
Hg.3 The average rate of infusion of Pendiomide was 5 mg. per minute, of hexamethonium, 4 mg. per minute, and of Arfonad, 7 mg. per minlido)-l, 2-trimethylene thiophanium d-camphor sulfonate) furnished through the courtesy of Hoffmann-LaRoche, Inc. ganglionic blockade, if this response in man is of the same order of sensitivity as it is in the dog.
After the blood pressure was maintained at hypotensive ranges for 15 to 20 minutes, observations on cerebral blood flow were again made. The infusion of the ganglionic blocking drug was then continued and norepinephrine or Aramine was infused as rapidly as necessary to return the blood pressure to or above the control observations. After the blood pressure was restabilized at this level, the cerebral blood flow was again determined and the results compared with those obtained on the patients in group 1 in whom the same vasopressor agents were administered to normotensive subjects whose blood pressures were subsequently increased to hypertensive levels. ;
t The absolute increase in blood pressure (mm. Hg) after the vasopressor agent was somewhat greater in the patients in group 2 as compared with group 1 and the percentile increase was considerably larger.
RESULTS
The mean arterial blood pressure was increased about 36 per cent on the average for the group of patients receiving Aramine alone.
This was due to a rise in both systolic and diastolic pressure and was associated with a sharp increase in cerebrovascular resistance which was statistically significant (p less than 0.10). The response to norepinephrine was similar (p less than 0.02). When the observations on the response to Aramine and norepinephrine were combined the increase in cerebrovascular resistance was highly significant (p less than 0.01). There was frequently a reduction in cerebral blood flow during the administration of Aramine quite similar to that seen in patients receiving norepinephrine (4) ( cerebral vessels which is somewhat greater than on the over-all circulatory bed. As a result, the cerebral blood flow is slightly decreased in some instances. A different set of circumstances exist when the blood pressure is reduced to hypotensive ranges. Since the cerebral circulation is probably not under the regulation of the autonomic nervous system,1 the cerebral circulation will be more dependent (passively) on systemic blood pressure and local cerebral tissue factors which are responsible for maintaining cerebrovascular resistance than is true of the general circulation. Therefore, when the blood pressure is moderately reduced, the cerebral blood flow also decreases unless local tissue factors act in such a manner as to produce vasodilatation (active or passive) and thus return the blood flow to the control levels. The net result will depend on the intensity of the individual opposing forces.
When the systemic blood pressure is reduced with ganglionic blocking agents, cerebral blood flow is depressed. This is quickly reversed when the blood pressure is returned to control levels with norepinephrine or Aramine. depressed and cerebral oxygen uptake (CMRO,) moderately so. Following an infusion of Aramine the blood pressure was increased. This was associated with a return of cerebral blood flow and CMRO2 toward the control levels. There was essentially no difference between the response to norepinephrine-( fig. 1 ) and the response to Aramine. or shock due to other causes. Under these circumstances cerebral blood flow would probably be depressed. Administering a vasopressor agent and thus raising the blood pressure towards normotensive levels could then be expected to increase cerebral blood flow towards normal. This suggests that improvement in the cerebral circulation can be expected to follow the use of vasopressor agents when used to increase the blood pressure from hypotensive levels to normotensive ones during the treatment of hypotensive states resulting from numerous causes. This is in direct contrast to the response when these vasopressor agents are used to raise the blood pressure from normotensive levels to hypertensive ones. SUMMARY AND CONCLUSIONS 1. Observations were made on the cerebral hemodynamic response to raising the blood pressure from normotensive levels to hypertensive ones through the use of a continuous infusion of Aramine or norepinephrine. As the blood pressure increased, cerebral blood flow decreased. 269 I 2. When the blood pressure was reduced by the use of ganglionic blocking agents (Arfonad, hexamethonium, or Pendiomide), cerebral blood flow was depressed. The extent of depression was usually greatest in the patients with marked hypotension. As the cerebral blood flow decreased, cerebral oxygen consumption was partially maintained due to a more complete extraction of oxygen from the blood flowing through the brain. However, compensation was inadequate and cerebral anoxia was observed in several of the patients who developed very marked hypotension. When the blood pressure was returned from hypotensive levels to normotensive ranges by administering Aramine or norepinephrine, the cerebral blood flow actually increased. This response was in sharp contrast to raising the pressure from normotensive to hypertensive levels.
3. These observations suggest that when vasopressor agents are used for the treatment of severe hypotension, the therapist can expect an increase in cerebral blood flow and improvement of cerebral function.
SUMARIO ESPA~OL
1. Observaciones fueron hechas en la respuesta de la hemodinamica cerebral al incremento de la presion arterial de niveles normotensos a niveles hipertensos mediante el uso de una infusion continua de Aramine o norepinefrina. A medida que la presi6n aument6 la cir-culaci6n cerebral disminuy6.
2. Cuando la presi6n arterial fu6 reducida con el uso de agentes bloqueadores gangli6nicos (Arfonad, hexamethonium o Pendiomide), la circulaci6n cerebral disminuy6. La extensi6n del decremento fu6 usualmente mayor en los pacientes con marcada hipotensi6n. A medida que la circulaci6n cerebral disminuy6, el consumo de oxigeno cerebral fu6 parcialmente mantenido debido a una mas completa extrac-ci6n de oxigeno de la circulaci6n sanguinea cerebral. Sinembargo, la compensaci6n fue ina-decuada y anoxia cerebral se observ6 en diferentes pacientes que desarrollaron muy marcada hipotensi6n. Cuando la presi6n arterial retorn6 de niveles hipotensos a niveles normotensos mediante la administraci6n de Aramine o norepinefrina, la circulaci6n cerebral actualmente aument6. Esta respuesta estuvo en contraste agudo con la obtenida cuando se au-ment6 la presi6n de niveles normotensos a hipertensos.
3. Estas observaciones sugieren que cuando agentes vasopresores se usan para el tratamiento de la hipotension marcada, el terapeuta puede esperar un incremento en la circulaci6n cerebral y una mejoria en la funcion cerebral.
